MedPath

Comparison of intravenous syntocinon in the third stage of labor with rectal misoprostol abortions after the second trimester of pregnancy

Phase 2
Conditions
Intravenous syntocinon in the third stage of labor associated with rectal misoprostol abortions after the second trimester of pregnancy.
Oxytocic drugs
Registration Number
IRCT2015020715795N2
Lead Sponsor
Ardabil University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
100
Inclusion Criteria

Inclusion criteria were: legal permission to go to the end of pregnancy; intrauterine fetal death; gestational age 14 to 18 weeks; premature rupture approved exclusion criteria of the study: allergy or intolerance known as misoprostol; high blood pressure 160/90; severe cardiovascular disease; the patient's general condition is very bad; history of previous uterine scar (except single layer lower uterine segment caesarean section with a transverse incision); severe anemia; coagulation; anticoagulation; active liver disease; uncontrolled seizure disorders; Addison's disease; steroid use

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The time of placental removal. Timepoint: After fetus delivery. Method of measurement: Time.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath